E
Edward A. Gill
Researcher at University of Washington
Publications - 82
Citations - 7092
Edward A. Gill is an academic researcher from University of Washington. The author has contributed to research in topics: Patent foramen ovale & Heart failure. The author has an hindex of 29, co-authored 77 publications receiving 6506 citations. Previous affiliations of Edward A. Gill include University of Utah & Harborview Medical Center.
Papers
More filters
Journal ArticleDOI
Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts
Michael A. Laflamme,Kent Chen,Anna V. Naumova,Veronica Muskheli,James A. Fugate,Sarah K. Dupras,Hans Reinecke,Chunhui Xu,Mohammad Hassanipour,Chris O'Sullivan,Lila R. Collins,Yinhong Chen,Elina Minami,Edward A. Gill,Shuichi Ueno,Chun Yuan,Joseph K. Gold,Charles E. Murry +17 more
TL;DR: This work generated highly purified human cardiomyocytes using a readily scalable system for directed differentiation that relies on activin A and BMP4, and identified a cocktail of pro-survival factors that limitsCardiomyocyte death after transplantation.
Journal ArticleDOI
Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts
James J.H. Chong,Xiulan Yang,Creighton W. Don,Elina Minami,Yen-Wen Liu,Jill J. Weyers,William M. Mahoney,Benjamin Van Biber,Savannah Cook,Nathan J. Palpant,Jay Gantz,James A. Fugate,Veronica Muskheli,G. Michael Gough,Keith W. Vogel,Cliff A. Astley,Charlotte E. Hotchkiss,Audrey Baldessari,Lil Pabon,Hans Reinecke,Edward A. Gill,Veronica Nelson,Hans-Peter Kiem,Hans-Peter Kiem,Michael A. Laflamme,Charles E. Murry +25 more
TL;DR: It is shown that hESC-CMs can be produced at a clinical scale (more than one billion cells per batch) and cryopreserved with good viability and can remuscularize substantial amounts of the infarcted monkey heart.
Journal ArticleDOI
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report
Terry A. Jacobson,Matthew K. Ito,Kevin C. Maki,Carl E. Orringer,Harold E. Bays,Peter B. Jones,James M. McKenney,Scott M. Grundy,Edward A. Gill,Robert A. Wild,Don P. Wilson,W. Virgil Brown +11 more
TL;DR: This document provides support for a consensus set of recommendations for patient-centered management of dyslipidemia in clinical medicine and an elevated level of cholesterol carried by circulating apolipoprotein B-containing lipoproteins is a root cause of atherosclerosis.
Journal ArticleDOI
National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary
Terry A. Jacobson,Matthew K. Ito,Kevin C. Maki,Carl E. Orringer,Harold E. Bays,Peter B. Jones,James M. McKenney,Scott M. Grundy,Edward A. Gill,Robert A. Wild,Don P. Wilson,W. Virgil Brown +11 more
TL;DR: The current Executive Summary highlights the major conclusions in Part 1 of the recommendations report of the NLA Expert Panel, which includes screening and classification of lipoprotein lipid levels in adults and targets for intervention in dyslipidemia management.
Journal ArticleDOI
The bicuspid aortic valve: an integrated phenotypic classification of leaflet morphology and aortic root shape.
Benjamin M. Schaefer,Mark B. Lewin,Karen K. Stout,Edward A. Gill,Allison Prueitt,Peter H. Byers,Catherine M Otto +6 more
TL;DR: Type 1 BAV is associated with male gender and normal aortic shape but a larger sinus diameter, and type 2 leaflet morphology isassociated with ascending aorta dilatation , larger arch dimensions and higher prevalence of myxomatous mitral valve disease.